Ascendiant Capital Initiates Coverage of Cyclo Therapeutics (CYTH) with Buy Recommendation

4d ago, source:

Fintel reports that on April 22, 2024, Ascendiant Capital initiated coverage of Cyclo Therapeutics ( NasdaqCM:CYTH) with a Buy recommendation.

Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)

4d ago, source:

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cyclo Therapeutics (CYTH – Research Report), ...

Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

1mon ago, source: Yahoo Finance

March 18, 2024--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines ...

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

on MSN ago, source:

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus erythematosus ...

JP Morgan Upgrades CytomX Therapeutics (CTMX)

4d ago, source: Fintel on MSN

Fintel reports that on April 22, 2024, JP Morgan upgraded their outlook for CytomX Therapeutics (NasdaqGS:CTMX) from ...

Unicycive Therapeutics (UNCY) Price Target Increased by 21.14% to 5.41

9d ago, source: Fintel on MSN

The average one-year price target for Unicycive Therapeutics (NasdaqCM:UNCY) has been revised to 5.41 / share. This is an ...

Analyzing the Price-to-Earnings Ratio of Cullinan Therapeutics Inc (CGEM)

4d ago, source: newsheater

Based on Cullinan Therapeutics Inc (CGEM), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -37.4. The debt to equity ...

C4 Therapeutics Inc (CCCC) Stock: Evaluating the Market Performance

8d ago, source: newsheater

To wrap up, the performance of C4 Therapeutics Inc (CCCC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the ...